Search

everythinglearnresearchcommunity

for

Search:↓

Calcipotriol's effectiveness for treating alopecia areata is unclear and needs more research.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Enhancing melanin's energy generation may help treat alopecia areata.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Herbal lotions are effective for severe hair loss, with a 64.8% success rate, but relapse is common and long-term management requires allergen control and possible corticosteroid use.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Alopecia areata may be linked to hearing problems, so patients should monitor their hearing.

There's no link between low iron levels and the hair loss condition, alopecia areata.

Both treatments helped hair regrowth in alopecia areata, with isopropanol being better tolerated.

Hair follicles are smaller in people with androgenetic alopecia compared to those with normal scalps.

The document concludes that new treatments for hair loss may involve a combination of cosmetics, clinical methods, and genetic approaches.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Injecting vitamin D3 into the skin is an effective treatment for patchy hair loss.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

A woman with a rare scalp condition causing a thick scalp and hair loss didn't improve with steroid treatment.